期刊
SCIENCE BULLETIN
卷 65, 期 17, 页码 1489-1504出版社
ELSEVIER
DOI: 10.1016/j.scib.2020.04.012
关键词
Cancer immunotherapy; Local drug delivery system; Scaffold; Hydrogel; Controlled drug delivery; Combination therapy
资金
- National Natural Science Foundation of China [31900945]
- Basic Research Program of Shenzhen [JCYJ20170412111100742, JCYJ20180507182413022]
- Fok YingTong Education Foundation for Young Teachers in the Higher Education Institutions of China [161032]
- Postdoctoral Science Foundation of China [2018M643175]
- Guangdong Province Natural Science Foundation of Major Basic Research and Cultivation Project [2018B030308003]
Immunotherapy has attracted tremendous attention due to the remarkable clinical successes for treating a broad spectrum of tumors. One challenge for cancer immunotherapy is the inability to control localization and sustain concentrations of therapeutics at tumor sites. Local drug delivery systems (LDDSs) like the biomaterial scaffold-based drug delivery systems have emerged as a promising approach for delivering immunotherapeutic agents facilely and intensively in situ with reduced systemic toxicity. In this review, recent advances in biomaterial scaffold-based LDDSs for the administration of immunotherapeutic agents including vaccines, immunomodulators, and immune cells are summarized. Moreover, co-delivery systems are also evaluated for local immunotherapy-involving combination anti-tumor therapy, including chemotherapy-immunotherapy, photothermal-immunotherapy, and other combination therapies. Finally, the current challenges and future perspectives on the development of next-generation LDDSs for cancer immunotherapy are discussed. (C) 2020 Science China Press. Published by Elsevier B.V. and Science China Press. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据